drugset / Trial / NCT00626184
A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease
Non-randomizedCrossoverSingle-blindTreatment
Summary
To assess safety and tolerability of ALV003 in healthy volunteers and patients with Celiac Disease
Timeline
- Start
- 2008-02
- Primary completion
- 2008-05
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Latiglutenase | Protein / enzyme biologic | — | — |